These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

168 related items for PubMed ID: 8239902

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Local and systemic antitumor response after combined therapy of mouse metastatic tumors with tumor cells expressing IFN-alpha and HSVtk: perspectives for the generation of cancer vaccines.
    Santodonato L, D'Agostino G, Santini SM, Carlei D, Musiani P, Modesti A, Signorelli P, Belardelli F, Ferrantini M.
    Gene Ther; 1997 Nov; 4(11):1246-55. PubMed ID: 9425449
    [Abstract] [Full Text] [Related]

  • 27. Dendritic cells in antitumor immune responses. II. Dendritic cells grown from bone marrow precursors, but not mature DC from tumor-bearing mice, are effective antigen carriers in the therapy of established tumors.
    Gabrilovich DI, Nadaf S, Corak J, Berzofsky JA, Carbone DP.
    Cell Immunol; 1996 May 25; 170(1):111-9. PubMed ID: 8665591
    [Abstract] [Full Text] [Related]

  • 28. Preliminary observations on the effect of glucan in combination with radiation and chemotherapy in four murine tumors.
    Stewart CC, Valeriote FA, Perez CA.
    Cancer Treat Rep; 1978 Nov 25; 62(11):1867-72. PubMed ID: 728904
    [Abstract] [Full Text] [Related]

  • 29. Antitumor protection using murine dendritic cells pulsed with acid-eluted peptides from in vivo grown tumors of different immunogenicities.
    Ribas A, Bui LA, Butterfield LH, Vollmer CM, Jilani SM, Dissette VB, Glaspy JA, McBride WH, Economou JS.
    Anticancer Res; 1999 Nov 25; 19(2A):1165-70. PubMed ID: 10368670
    [Abstract] [Full Text] [Related]

  • 30. Embryonal mass and hormone-associated effects of pregnancy inducing a differential growth of four murine tumors.
    Bustuoabad OD, di Gianni PD, Franco M, Kordon EC, Vanzulli SI, Meiss RP, Grion LC, Díaz GS, Nosetto SH, Hockl P, Lombardi MG, Pasqualini CD, Ruggiero RA.
    Oncol Res; 2002 Nov 25; 13(3):147-60. PubMed ID: 12549624
    [Abstract] [Full Text] [Related]

  • 31. Marked antiangiogenic and antitumor efficacy of AG3340 in chemoresistant human non-small cell lung cancer tumors: single agent and combination chemotherapy studies.
    Shalinsky DR, Brekken J, Zou H, Bloom LA, McDermott CD, Zook S, Varki NM, Appelt K.
    Clin Cancer Res; 1999 Jul 25; 5(7):1905-17. PubMed ID: 10430098
    [Abstract] [Full Text] [Related]

  • 32. Combination chemotherapy and IL-15 administration induce permanent tumor regression in a mouse lung tumor model: NK and T cell-mediated effects antagonized by B cells.
    Chapoval AI, Fuller JA, Kremlev SG, Kamdar SJ, Evans R.
    J Immunol; 1998 Dec 15; 161(12):6977-84. PubMed ID: 9862733
    [Abstract] [Full Text] [Related]

  • 33. Use of protamine to augment adenovirus-mediated cancer gene therapy.
    Lanuti M, Kouri CE, Force S, Chang M, Amin K, Xu K, Blair I, Kaiser L, Albelda S.
    Gene Ther; 1999 Sep 15; 6(9):1600-10. PubMed ID: 10490770
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Transplantable IgD immunoglobulin-secreting tumors in rat.
    Bazin H, Beckers A, Urbain-Vansanten G, Pauwels R, Bruyns C, Tilkin AF, Platteau B, Urbain J.
    J Immunol; 1978 Nov 15; 121(5):2077-82. PubMed ID: 712079
    [Abstract] [Full Text] [Related]

  • 36. Non-H-2 restriction specificity of tumor-regressor mouse sera with regard to their activity to inhibit tumor cell transplantation.
    Egawa K, Kiyohara T, Tanino T.
    Jpn J Exp Med; 1982 Oct 15; 52(5):255-60. PubMed ID: 7169670
    [Abstract] [Full Text] [Related]

  • 37. Antitumor activity of a novel podophyllotoxin derivative (TOP-53) against lung cancer and lung metastatic cancer.
    Utsugi T, Shibata J, Sugimoto Y, Aoyagi K, Wierzba K, Kobunai T, Terada T, Oh-hara T, Tsuruo T, Yamada Y.
    Cancer Res; 1996 Jun 15; 56(12):2809-14. PubMed ID: 8665518
    [Abstract] [Full Text] [Related]

  • 38. Hexamethylmelamine-induced regression of human lung tumors growing in immune deprived mice.
    Mitchley BC, Clarke SA, Connors TA, Neville AM.
    Cancer Res; 1975 Apr 15; 35(4):1099-102. PubMed ID: 1116144
    [Abstract] [Full Text] [Related]

  • 39. Efficacy of liposomes and hyperthermia in a human tumor xenograft model: importance of triggered drug release.
    Kong G, Anyarambhatla G, Petros WP, Braun RD, Colvin OM, Needham D, Dewhirst MW.
    Cancer Res; 2000 Dec 15; 60(24):6950-7. PubMed ID: 11156395
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.